Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC, namely 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC), are in dynamic existence and have distinct regulatory functions. In the current study, we investigated whether there are changes in the contents of all three 5mC-oxidized derivatives in the hepatocellular carcinoma (HCC) genome and further explored the underlying mechanisms. We showed that both global genomic 5hmC and 5fC contents were decreased significantly in 
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In recent years, studies have found that hydroxymethylation (5-hydroxymethylcytosine [5hmC]) occurs in mammalian genomic DNA, and 5hmC is produced from 5mC by the catalytic activity of ten-eleven translocation family enzymes (TETs, including TET1, TET2, and TET3). Additionally, oxygen, Fe(II), and alpha-ketoglutarate (α-KG) are required for TET enzymes to catalyze 5mC oxidation, whereas accumulation of 2-hydroxyglutarate (2-HG), which shares structural similarity with α-KG, can exert an inhibiting effect. (4, 5) The content of 5hmC is an order of magnitude lower than that of 5mC in the whole genome. It has been reported that the genomic 5hmC content is decreased overall in tumor tissues. (6) (7) (8) (9) Although it is believed that this may be due to decreased catalytic activity of the mutant Tets or decreased expressions of TETs, (7) a full understanding of the exact mechanism is still absent.
In addition, we (10) and others (11) found that 5hmC can be further oxidized by TETs to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), both of which are lower than 5hmC in the mammalian genome by about two and three orders of magnitude, respectively. 5fC and 5caC can be removed by thymine DNA glycosylase (TDG) and then replaced with unmodified cytosine, to complete the process of active demethylation. (7, 10, 12, 13) Whether there are changes in the contents of 5fC and 5caC in the tumor cell genome has not been reported yet.
The specific physiological functions of 5hmC, 5fC, or 5caC in the genome are not yet clear. However, lines of evidence suggest that these oxidized cytosines are not short-lived transient intermediates in an enzymatic process leading to DNA demethylation but are instead integrated in genomic DNA, can be stable, and may serve unique and distinct regulatory functions in the mammalian genome. (7, (14) (15) (16) For example, genome-wide profiling of 5fC identified 5fC enrichment at active enhancers and revealed its possible roles in epigenetic priming (17, 18) ; numerous readers for 5hmC, 5fC, or 5caC, including transcriptional regulators, DNA repair factors, and chromatin regulators, were identified; and 5hmC, 5fC, and 5caC may exert different epigenetic signaling functions by recruiting their specific binders or readers. (19) (20) (21) Furthermore, 5fC and 5caC may reduce the rate and substrate specificity of RNA polymerase II transcription. (22) Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third most frequent cause of cancer-related deaths worldwide, with an estimated 500,000-600,000 deaths each year. (23) (24) (25) Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of HCC. Asian and African countries, especially China, generally show a predominance of HBV. (26) (27) (28) For HBV-related HCC, it is believed that both genetic and epigenetic alterations play vital roles in hepatocarcinogenesis through direct and indirect mechanisms initiated by HBV. (29) (30) (31) (32) aRtiCle iNFoRMatioN:
In this report, we found that in addition to the lower global genomic 5hmC content in HCC tissues compared to paratumor tissues, the 5fC content decreased in HCC tissues. Furthermore, we found that HBV infection could aggravate the abnormality of cytosine modifications. 
Materials and Methods

patieNtS aND HCC SaMpleS
Cell CultuRe
Cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum at 37C and 5% CO 2 . The cells were harvested by trypsinization at 80%-90% confluence and washed with cold phosphate-buffered saline 3 times, then stored at −80C until DNA, RNA, or metabolite extraction.
CHeMiCalS
For DNA modification analysis, 5hmC, 5fC, 5caC, and 5mC were obtained from Berry 
DNa eXtRaCtioN aND DigeStioN
Cell or tissue genomic DNA was extracted using the phenol/chloroform method. Each 5 μg of purified genomic DNA was then digested into mononucleosides with 0.5 U DNase I, 0.002 U SVP, and 1.5 U CIP at 37C overnight as described. (33, 34) After digestion, the samples were filtered by ultrafiltration (molecular weight cutoff, 3 kDa; Pall, Port Washington, NY), and then the filtrates containing mono-deoxynucleosides were subjected to ultra-high-performance liquid chromatography tandem mass-spectrometry (UHPLC-MS/MS).
uHplC-MS/MS FoR DNa MoDiFiCatioN aNalySiS
UHPLC-MS/MS analysis was performed on the Agilent 1290 II UHPLC system coupled with an electrospray ionization-triple quadrupole mass spectrometer (G6495; Agilent Technologies, Palo Alto, CA). A Zorbax Eclipse Plus C18 column (2.0 × 100 mm inner diameter, 1.8 μm particle size; Agilent Technologies) was used in this system to analyze all mononucleosides. Each sample was injected with a volume of 5 μL and analyzed 3 times at least. Detailed methods for DNA modification analysis are provided in the Supporting Information. 
eXtRaCtioN oF tHe iNtRaCellulaR MetaBoliteS
uHplC-MS/MS FoR α-Kg aND 2-Hg aNalySiS
The analysis was performed on an Agilent 1290 UHPLC system coupled to an Agilent 6470A Triple Quadrupole MS System (Agilent Technologies). Detailed methods are provided in the Supporting Information.
geNe eXpReSSioN aNalySiS
Total RNA was isolated from tissues or cells with TRIzol reagent (Invitrogen, Carlsbad, CA). Gene expression level was determined by quantitative RT-PCR. Briefly, after DNase I treatment, complementary DNA was synthesized according to the manufacturer's instructions (Takara, Dalian, China). Quantitative PCR was carried out using SYBR Green Mix according to the manufacturer's instructions (Roche, Mannheim, Germany). Expression data were normalized to β-actin mRNA expression. The obtained data are presented in arbitrary units and were calculated using the formula 2 (−ΔCt β-actin -gene of interest)
. The sequences of the primers for human TET1, TET2, TET3, TDG, DNMT1, DNMT3A, DNMT3B, and β-actin are listed in Supporting Table S1 .
WeSteRN Blot aNalySiS
Whole-cell lysates were generated, and proteins were separated by 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by transfer to polyvinylidene difluoride membranes. The membranes were washed and blocked. The primary antibodies and dilutions used were as follows: TET1 (1:500, clone ab191698; Abcam, Cambridge, MA), TET2 (1:1,000, clone ab94580; Abcam), TET3 (1:500, clone ab139311; Abcam), and β-actin (1:2,000, sc-1616; Santa Cruz Biotechnology). Samples were incubated with primary antibodies and then analyzed using an IRDye 800CW-conjugated antibody and the LI-COR imaging system (LI-COR Biosciences).
StatiStiCal aNalySiS
All measurement data were expressed as mean ± SD. SPSS software (version 16.0; SPSS Inc., Chicago, IL) was used for statistical analyses. Differences between variables were assessed using two-tailed Student t tests. One-way ANOVA was used to compare means of three or more samples (using the F distribution). Kaplan-Meier and log-rank analyses were performed to evaluate the differences in survival rates. When data could not fit a Gaussian distribution, Wilcoxon matched-pairs signed rank test and MannWhitney test were used as two kinds of nonparametric tests.
The correlations between the content of 5mC and 5hmC, the content of 5hmC and 5fC or among the expression levels of DNA methylation-related enzymes were evaluated by Pearson's correlation analysis. For the correlations among DNA methylation-related enzymes, a value of P < 0.05 after multiple testing correction using the BenjaminiHochberg procedure was considered statistically significant. Analyses were performed using the professional statistical software GraphPad Prism, version 5.01.
Results
gloBal geNoMiC 5HMC aND 5FC CoNteNtS WeRe SigNiFiCaNtly DeCReaSeD iN tHe eaRly Stage oF HCC
Whole genomic DNA was extracted from matched pairs of HCC tissues and adjacent paratumor tissues and then subjected to UHPLC-MS/MS analysis for the detection of DNA cytosine modifications (5mC, 5hmC, 5fC, and 5caC) (Supporting Fig. S1 ). Consistent with reported results, (35) the content of 5hmC in HCC tissues of cohort 1 was significantly decreased compared to paratumor tissues (Fig. 1A) . Notably, we found that the content of 5fC, a product of 5hmC by TET enzymatic oxidation, was also significantly decreased in HCC tissues compared to paratumor tissues (Fig. 1B) . Thus, we show the change of the global 5fC content in the cancer genome. The 5caC content in HCC tissues was below the detection threshold of our instrument (Supporting Fig. S1D ).
In order to explore whether there was a significant global content change of 5hmC and 5fC in different stages of HCC, we compared the content of 5hmC or 5fC in tumor and paratumor tissues among different BCLC stages (23) (0, A, and B). The results in cohort 1 showed that the 5hmC content was significantly decreased in HCC tissues compared with paratumor tissues in the very early stage (0 stage). There was no significant change of 5hmC content in tumor tissues among stages 0, A, and B (Fig. 1C) . However, except that in the very early stage (stage 0), the content of 5fC in tumor tissues in stage A continued to decrease significantly compared with that in stage 0, yet there was no significant difference in stages A and B (Fig.  1D) . To confirm these results, we selected 52 newer patients (cohort 2), and all tumors were at stage A or B (BCLC staging, Table 1 ). Similarly, global content of genomic 5hmC and 5fC in this cohort decreased dramatically compared with the paratumor tissues (Supporting Fig. S2A,B) . However, there was no significant change of 5hmC or 5fC content between stage A and B both in HCC tissues and in paratumor tissues (Supporting Fig. S3A,B) . In addition, we analyzed 5hmC and 5fC contents based on tumor sizes in cohorts 1 and 2, and we found no significant differences in 5hmC or 5fC contents based on tumor size only (Supporting Fig. S4A,B) . Taken together, these results indicate that global decreases of 5hmC and 5fC content in HCC genomic DNA occur in the very early stage (BCLC staging 0) of HCC and that 5fC levels are further decreased from stage 0 to stage A of HCC.
tHe DeCReaSe oF 5HMC aND 5FC CoNteNtS iN HCC geNoMiC DNa WaS aSSoCiateD WitH HBV iNFeCtioN
Detection of HBV DNA in the blood is considered to be a more accurate indicator of an immediate HBV infection status. We divided the patients into an HBV DNA-low group and an HBV DNAhigh group according to HBV DNA level. In cohort 1, we found that in the early stage of HCC (BCLC stages 0 and A), although the 5hmC and 5fC content in paratumor tissues did not show a significant difference between the two groups, the 5hmC and 5fC contents in HCC tissues were decreased more significantly in the HBV DNA-high group ( Fig.  2A,B) . However, this difference between the two groups at later stages of HCC (cohort 2, ≥3 cm HCC and BCLC staging A and B) became insignificant (Supporting Fig. S5A,B) .
To confirm whether HBV infection does result in a decrease in 5hmC and 5fC content in HCC cells, we analyzed two HCC cell lines which had been integrated with HBV DNA. One cell line is HepG2.2.15, integrated with complete HBV DNA (36) ; and the other is Huh7, integrated with the gene HBx. (37) HBV X protein (HBx) is a crucial determinant for regulating HBV activity. (31) We found that the global contents of 5hmC and 5fC were significantly decreased in the genome of both cell lines integrated with HBV DNA compared with their original cells (Fig. 2C,D) , and the decreases were even more significant than that in HCC tissues (comparing Fig. 2C,D with Fig. 2A,B) . Taken together, these results indicate that HCC tumor cells have decreased 5hmC and 5fC contents in genomic DNA and that HBV infection could cause more severe abnormality. Subsequently, in a preliminary effort, we studied the underlying mechanisms.
tHe gloBal geNoMiC 5MC CoNteNt WaS DeCReaSeD iN tHe eaRly Stage oF HCC aND WaS aSSoCiateD WitH HBV iNFeCtioN
It is known that cancer cells manifest genomewide hypomethylation, and previous reports have shown that the global 5mC content in the genome was decreased in tumor tissues, (2) including HCC. (35) We also analyzed global 5mC content in HCC tissues of patients in cohorts 1 and 2. We found that 5mC content did show a significant decrease in HCC tissues compared with paratumor tissues at the early stage of HCC as in cohort 1 and a slight and insignificant decrease in cohort 2 ( Fig. 3A ; Supporting Fig. S6 ). 5mC content had a positive correlation with 5hmC content, and 5hmC content had a positive correlation with 5fC content, in both tumor tissues and paratumor tissues (Supporting Fig. S7 ), suggesting that an important attributing factor for the decrease of 5hmC and 5fC was the decrease of 5mC. Interestingly, we found that HBV infection was also associated with 5mC decrease. The 5mC content in the early stage of HCC tissues was decreased more significantly in the HBV DNA-high group (Fig. 3B) . Consistent with this result was that cell lines integrated with HBV DNA also showed a significant decrease of 5mC content compared with their original cells (Fig. 3C) . Taken together, these results indicate that the decrease of 5hmC and 5fC in HCC may be partly due to the decrease of 5mC as 5hmC and 5fC are produced from 5mC gradually, while HBV infection may aggravate this decrease.
tHe eXpReSSioN leVel oF tet geNeS aND tHe CoNteNt oF α-Kg WeRe DeCReaSeD iN HCC
Studies have found that the expression level of TET enzymes was decreased in a variety of tumors, including HCC. (8) We also examined the gene expression levels of DNA methylation-related enzymes in HCC tissues in cohorts 1 and 2. A significant decrease in the expression level of TET2 in tumor tissues was seen compared to paratumor tissues (Fig. 4B ), but we only found in cohort 2 a slight decrease in TET1 and TET3 expression (Fig.  4A,C) . Although we found no significant effect of HBV infection on the expression of the TET enzymes in HCC tumor tissues (Supporting Fig.  S8 ), we observed a decrease in TET2 and TET3 expression in both cell lines integrated with HBV DNA (Supporting Fig. S9 ). However, it is strange that there was a significant increase in TET1 expression in HBV DNA-integrated cell lines (Supporting Fig. S9 ), which may be a compensatory response to the simultaneous decrease in TET2 and TET3 expression during cell culture. The different effect of HBV on TET expression in HCC tumor tissues and in HCC culture cells may be due to the different cell state and cellular microenvironment. (38, 39) The activity of TET enzymes can be stimulated or inhibited in the presence of distinct metabolites, cofactors, and posttranslational modifications. (7) Evidence showed that α-KG, the major cofactor and cosubstrate of TET enzymes, was a critical factor in the regulation of 5hmC dynamics in vivo. (40) We also examined the content of α-KG in tumor and paratumor tissues of HCC using UHPLC-MS/MS. We found that the α-KG content was decreased significantly in tumor tissues compared to paratumor tissues (Fig. 4D) . In addition, interestingly, 2-HG, a mutant product and antagonist of α-KG, (41) showed a slight and insignificant increase in tumor tissues compared with paratumor tissues (Supporting Fig. S10 ). The effects of the two changes (decrease in α-KG content and increase in 2-HG content) are consistent, and both can result in a decrease in TET enzyme activity. We observed no significant effect of HBV infection on the content of α-KG or 2-HG in HCC tissues (Supporting Fig. S11 ). Taken together, the decreased expression of TET enzymes and the decreased content of α-KG (and possibly the increased content of 2-HG) could attenuate the catalytic activity of TET enzymes, resulting in a decrease in 5hmC and 5fC content in HCC genomic DNA.
uNCooRDiNateD eXpReSSioN oF DNa MetHylatioNRelateD eNZyMeS iN HCC
It is now known that DNA methylation and active demethylation are regulated by a series of DNA methylation-related enzymes, including DNMTs, TETs, and maybe TDG for DNA demethylation. Precise regulation of DNA methylation patterns is important for normal development and provides a fundamental protection against cellular transformation.
(7) We previously found that DNA methylation-related enzymes were positively correlated in normal mouse and human tissues, and gene expression RNA-sequencing data from The Cancer Genome Atlas and GenotypeTissue Expression databases suggested that these correlations were generally lower in tumor tissues than in the corresponding normal tissues. However, these correlations in HCC tissues were not significantly lower than those in normal liver tissues. (42) Considering that direct quantitative RNA detection using quantitative RT-PCR is a gold standard for the determination of differential gene expression, (43) we also examined the expression of four other DNA methylation-related enzymes (TDG, DNMT1, DNMT3A, and DNMT3B) using quantitative RT-PCR in addition to the three TET enzymes described above. Notably, we found that the expression levels of most of these enzymes were significantly positively correlated in paratumor tissues but that these correlations were generally attenuated or disappeared in HCC tissues, especially the correlations between TETs and DNMT1 or TDG (Fig. 5) . In addition, we divided all patients in cohorts 1 and 2 into high and low groups according to the 5hmC or 5fC median content in HCC tissues. The enzyme pairs TET1-TDG, TET1-DNMT1, TET2-TDG, and TET2-DNMT1 may have direct roles in determining 5hmC and 5fC contents. We found that the correlations between these enzyme pairs in 5hmC or 5fC low groups further declined compared with high groups (Supporting Fig. S12 , with the exception of the correlation of TET2-DNMT1 in 5hmC). Taken together, these results suggest that uncoordinated expression of DNA methylation-related enzymes may also be involved in the decrease of 5hmC, 5fC, or 5mC content in HCC genomic DNA. 
DeCReaSeD 5HMC aND 5FC CoNteNtS iN HCC geNoMiC DNa WeRe aSSoCiateD WitH pooR pRogNoSiS oF patieNtS
It has been reported that a decrease in 5hmC in tumor tissues was associated with poor prognosis. (9, 35) We found that, in addition to 5hmC, 5fC content in genomic DNA was associated with prognosis. Patients with low 5hmC or 5fC content in HCC tissues had worse disease-free survival (DFS) and overall survival (OS) rates than those with high 5hmC or 5fC content, respectively (Fig. 6) . Furthermore, we also found that 5hmC or 5fC content in paratumor tissues was associated with OS but only the decrease of 5fC content in paratumor tissues was significantly associated with worse DFS (Supporting Fig. S13 ).
Discussion
In the present study, we found that the global genomic 5hmC and 5fC contents were decreased in the early stage of HCC tissues. The underlying mechanisms for such decreases include (1) the decrease of 5mC content; (2) the decreased expression level of TET2 enzyme and the decreased content of α-KG, a cofactor of TET enzymes; (3) uncoordinated expression of DNA methylation-related enzymes; (4) HBV infection, which may be indirectly involved. In addition, we found that the decreases of 5hmC and 5fC contents were associated with the poor prognosis of HCC.
In this study, we report a decrease in global 5fC content in the HCC genome. The decrease could be expected theoretically. Because 5fC is a downstream oxidation product of 5hmC, which is also produced from 5mC oxidation catalyzed by TET enzymes, the decrease of 5fC is theoretically possible due to the decreased 5hmC content in HCC tissues. Our experimental results also support this prediction. We found that both 5fC and 5hmC contents were positively correlated within HCC and paratumor tissues (Supporting Fig. S7C,D) , and both were decreased in HCC tumor tissues. In addition, both the expression levels of TET enzymes and the content of α-KG were decreased in HCC tumor tissues (Fig. 4) , which further facilitated the decrease of 5fC content. Because 5hmC was reported to decrease in a variety of cancerous tissues, (6) (7) (8) (9) it is expected that 5fC may also be correspondingly decreased in these cancerous tissues other than in HCC.
Our results show that the changes of 5fC, a more downstream oxidation product of 5mC, are similar to those of 5hmC in HCC. Firstly, the content of both was significantly decreased in HCC tissues compared with paratumor tissues. Secondly, the underlying mechanisms for their decreases are similar: they are produced and catalyzed by the same class of enzymes (TETs), and there are significant positive correlations between 5hmC or 5fC and their direct substrates (5hmC and 5mC, 5fC and 5hmC). Lastly, their changes were significantly associated with the prognosis of HCC patients. But 5fC and 5hmC contents exhibit some different levels of change in HCC. For example, the 5hmC content in tumor tissues was decreased significantly in the very early stage (BCLC stage 0) of HCC and was not obviously changed after this period (BCLC stage 0 to A and A to B), while the 5fC content in tumor tissues was not only decreased in the very early stage (BCLC stage 0) of HCC but also further decreased from BCLC stage 0 to A (Fig. 1) . In addition, the content of 5fC in paratumor tissues revealed a value of DFS for HCC patients contrary to that of the content of 5hmC in paratumor (Supporting Fig. S13 ). As 5hmC and 5fC exert different epigenetic signaling functions by recruitment of their specific binders or "readers" (6) (7) (8) (9) and studies have shown that the genome-wide distribution of 5fC was different from that of 5hmC, (6) (7) (8) (9) 5hmC and 5fC may have the potential to be used in combination as biomarkers of cancer, which may be more precise than one marker used. Further studies involving more HCC patients with prognostic information can accurately evaluate the potential clinical use of these epigenetic markers in combination.
Our study found that HBV infection was associated with decreases of 5mC, 5hmC, and 5fC contents in HCC; and the results in HBV DNA-integrated cell lines further confirmed this association. Because HBV had little effect on the expression of Tet genes (Supporting Fig. S8 ) and on the content of α-KG and 2-HG (Supporting Fig. S11 ), HBV may mainly affect the decrease of 5mC content (this was more pronounced in HBV DNA-integrated cell lines), which may lead to a further decrease in 5hmC and 5fC contents. In other words, the direct impact of HBV on 5hmC and 5fC contents seems to be small. HBV may affect 5mC content in tumor cells in the early development of HCC, which appears to be slight in the following stages of HCC (BCLC stages A and B; Supporting Fig. S6) . By further analyzing the clinical and experimental data of this study, we observed no significant association between liver cirrhosis (a later event in the development of HCC) and 5mC, 5hmC, or 5fC content (data not shown). Consistent with this observation is that HBV may play a direct role in liver transformation (an early event in the development of HCC) and HBV-related HCC can arise in noncirrhotic liver. (29) Taken together, the decrease of 5mC, 5hmC, and 5fC content is more likely to be associated with the early development of HCC.
The reasons that HBV may affect the content of 5mC in HCC thus become of great interest to examine. It has been reported that HBV can affect the expression or activity of DNMTs. (30, (44) (45) (46) (47) However, the results of the reports are contradictory and confusing. We analyzed the expression levels of three DNMT genes (Dnmt1, Dnmt3a, and Dnmt3b) in HCC tumor and paratumor tissues and found no significant decrease in the expression of these genes in tumor tissues, also with no significant association between the levels of HBV DNA and the expression levels of these genes (data not shown). Interestingly, of the 31 previously reported HCC patients who were not infected with HBV or HCV but had a history of alcohol consumption, the same decrease in global genomic 5mC and 5hmC contents in HCC was observed, (35) suggesting that HBV infection is not a necessary factor for the global 5mC content decrease in HCC. The underlying linkages and mechanisms between HBV infection and the decrease of global 5mC content in HCC genomic DNA need further study.
The global genomic 5mC, 5hmC, and 5fC contents can be determined by both the expression levels of TET enzymes and the activities of these enzymes. Our results showed that both of them were changed in HCC. For example, we found a significant decrease in the expression level of TET2 in HCC tumor tissues compared to paratumor tissues (Fig. 4B) , and we also found uncoordinated expression of DNA methylation-related enzymes in HCC tumor tissues (Fig. 5) . In addition, we found that the α-KG content was decreased significantly in HCC tumor tissues (Fig. 4D) , which could result in a decrease in TET enzyme activity. However, except what we had examined in the present study, other factors that may affect the content of 5mC and 5mC oxidized derivatives need to be determined in futher studies-for example, those metabolites that affect the enzymatic activity of DNMTs and mutations in the genes of methylation-related enzymes.
In summary, the present study systematically reports changes in the global content of 5mC-oxidized derivatives in the HCC genome and their possible underlying mechanisms. Our research provides insight into the underlying mechanisms of changes of DNA 5mC-oxidized derivatives during HCC development, therefore enabling further and more extensive exploration. The change in 5fC content in HCC or combined with the change in 5hmC content could be potentially valuable for the evaluation of the prognosis of HCC patients. Further studies involving more HCC patients can be designed to detect the exact genomic regions with changed 5mC oxidized derivatives which may be associated with HCC development and the prognosis of patients.
